Abstract:BACKGROUND Many natural anthracycline glycoside antibiotics (AGAs), e.g. daunorubicin, are widely used as anticancer drugs in clinical practice, and their biosynthesis have been extensively studied. Epirubicin is a semi-synthesized derivative of daunorubicin, and more widely used in clinics due to its higher effectiveness and weaker toxicity than natural AGAs. However, the overall conversion rate of epirubicin from daunorubicin is only 15%. 4 '-Epidaunorubin is a crucial intermediate in semi-synthesis of epirubicin from daunorubicin. Much effort has been made to establish combinatorial biosynthesis approaches for production of 4 '-epidaunorubin, and 93 mg L-1 is the highest titer so far achieved. RESULTS CONCLUSION Daunorubicin-producing Streptomyces coeruleorubidus SL-7 were switched to 4 '-epidaunorubicin producer MSL201 by replacing dnmV with aveBIV. Then, continued to genetically modify MSL201 to increase production of 4 '-epidaunorubicin by in-frame knockout of dnrU and dnrX which catalyze conversion of daunorubicin to (13s)-13-dihydrodaunorubicin and baumycin-like compounds, respectively. The resulting strain MSL 203 was transformed by pSL206 containing a double aveBIV gene expression cassette to afford MSL 204, the 4 '-epidaunorubicin yield of which is 124.1 mg L-1, the highest yield of 4 '-epidaunorubicin ever obtained by fermentation methods. Knockout of the genes involved in consuming daunorubicin and increase of copy numbers of aveBIV gene can significantly improve the yield of 4 '-epidaunorubicin, giving the hitherto highest yield by a fermentation method. This result paves the way for commercial production of 4 '-epidaunorubicin via metabolic engineering approaches. (c) 2018 Society of Chemical Industry

Study on cloning and expression of daunorubicin C-14 hydroxylase gene under the control of SnpR-activated snpA promoter

Cloning and Expression of doxA Gene Encoding Daunorubicin C-14 Hydroxylase in E.coli and Its Purification

Bioconversion of Deoxysugar Moieties to the Biosynthetic Intermediates of Daunorubicin in an Engineered Strain of Streptomyces Coeruleobidus

Cloning and sequencing of daunomycin C-14 hydroxylase gene from Streptomyces coeruleorubidus SIPI1482

Rational Design of Daunorubicin C-14 Hydroxylase Based on the Understanding of Its Substrate-Binding Mechanism

Enhance 4′‐epidaunorubicin Production of Engineering Streptomyces Coeruleorubidus Strains Via Both Knockout of Daunorubicin‐consuming Enzymes Dnrx and Dnru, and Multiple Copies of Rate‐limiting Enzyme Avebiv

Enhancement of doxorubicin production in Streptomyces peucetius by genetic engineering and process optimization

Study on the separation and purification of 4'-epi-daunorubicin produced by gene engineering strain SIPI-A0707

Cloning and Disruption of dnmV from Daunorubicin-producing Strain Streptomyces coeruleorubidus SIPI-1482

Influence of Inactivation of dnrU Gene on Improvement of Daunorubicin Production

Cloning and Characterization of Purine Nucleoside Phosphorylase in Escherichia Coli and Subsequent Ribavirin Biosynthesis Using Immobilized Recombinant Cells

Overexpression of Avebiv Leading to the Improvement of 4′-Epidaunorubicin Production in Streptomyces Coeruleorubidus Strain SIPI-A0707

Construction of a High Epidaunorubicin-Producing Strain by Gene Recombination

Improved A40926 production from Nonomuraea gerenzanensis using the promoter engineering and the co-expression of crucial genes

Genetic engineering and heterologous expression of the disorazol biosynthetic gene cluster via Red/ET recombineering

Cloning and co-expression of d-amino acid oxidase and glutaryl-7-aminocephalosporanic acid acylase genes in Escherichia coli

A study to construct three prokaryotic expression vectors and its expression in adenosine deaminase

Cloning and expression of 2-deoxy-scyllo-inosamine dehydrogenase gene sisP from Micromonospora inyoensis

Enhancing A82846B Production by Artificial Attb-Assisted Overexpression of Orf10–orf11 Genes in Kibdelosporangium Aridum SIPI-3927

Cloning of the Multi-drug Resistance norAGene of Staphylococcus aureus and Its Prokaryotic Expression

Improvement of gougerotin and nikkomycin production by engineering their biosynthetic gene clusters